CXCR7 antagonists
US9783544B2 · kind B2 · utility
4Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 2015 |
| Grant date | Oct 10, 2017 |
| Priority date | — |
| Expiry date | Sep 12, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having formula I,or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, at least in part, on CXCR7 activity. Accordingly, the present invention provides in further aspects, compositions containing one or more of the above-noted compounds in admixture with a pharmaceutically acceptable excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.